4//SEC Filing
Southpoint Capital Advisors LP 4
Accession 0001012975-20-000407
CIK 0001211583other
Filed
May 5, 8:00 PM ET
Accepted
May 6, 4:05 PM ET
Size
12.1 KB
Accession
0001012975-20-000407
Insider Transaction Report
Form 4
Southpoint Capital Advisors LLC
10% Owner
Transactions
- Purchase
Common Stock
2020-05-04$6.25/sh+80,000$500,000→ 4,077,214 total(indirect: See Footnote)
Southpoint GP, LP
10% Owner
Transactions
- Purchase
Common Stock
2020-05-04$6.25/sh+80,000$500,000→ 4,077,214 total(indirect: See Footnote)
Southpoint Capital Advisors LP
10% Owner
Transactions
- Purchase
Common Stock
2020-05-04$6.25/sh+80,000$500,000→ 4,077,214 total(indirect: See Footnote)
Southpoint GP, LLC
10% Owner
Transactions
- Purchase
Common Stock
2020-05-04$6.25/sh+80,000$500,000→ 4,077,214 total(indirect: See Footnote)
Clark John Smith II
10% Owner
Transactions
- Purchase
Common Stock
2020-05-04$6.25/sh+80,000$500,000→ 4,077,214 total(indirect: See Footnote)
Footnotes (1)
- [F1]The securities are directly held by Southpoint Master Fund, LP for which Southpoint Capital Advisors LP serves as the investment manager and Southpoint GP, LP serves as the general partner. Southpoint Capital Advisors LLC serves as the general partner of Southpoint Capital Advisors LP and Southpoint GP, LLC serves as the general partner of Southpoint GP, LP. John S. Clark II serves as managing member of both Southpoint Capital Advisors LLC and Southpoint GP, LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest therein.
Documents
Issuer
FENNEC PHARMACEUTICALS INC.
CIK 0001211583
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001319998
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 4:05 PM ET
- Size
- 12.1 KB